I agree that this site is using cookies. You can find further informations here.
X
Pederson, Susan
105  results:
Search for persons X
?
1

Varied Patterns of Decay of Intact Human Immunodeficiency V..:

Gandhi, Rajesh T ; Bosch, Ronald J ; Mar, Hanna...
The Journal of Infectious Diseases.  227 (2023)  12 - p. 1376-1380 , 2023
Link: https://doi.org/10.1093/..
 
?
2

Tolerability of eptinezumab in overweight, obese or type 1 ..:

Baker, Brian ; Schaeffler, Barbara ; Hirman, Joe...
Endocrinology, Diabetes & Metabolism.  4 (2021)  2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
3

Clinical Immunogenicity Evaluation of Eptinezumab, a Therap..:

Pederson, Susan ; Biondi, David M. ; Allan, Brent...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
4

Corrigendum to "Eptinezumab for the Prevention of Episodic ..:

Smith, Timothy R. ; Janelidze, Marina ; Chakhava, George...
Clinical Therapeutics.  43 (2021)  4 - p. 791 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Eptinezumab for the prevention of chronic migraine: efficac..:

Silberstein, Stephen ; Diamond, Merle ; Hindiyeh, Nada A....
The Journal of Headache and Pain.  21 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
6

Selective Decay of Intact HIV-1 Proviral DNA on Antiretrovi..:

Gandhi, Rajesh T ; Cyktor, Joshua C ; Bosch, Ronald J...
The Journal of Infectious Diseases.  223 (2020)  2 - p. 225-233 , 2020
Link: https://doi.org/10.1093/..
 
?
7

Eptinezumab for the Prevention of Episodic Migraine: Sustai..:

Smith, Timothy R. ; Janelidze, Marina ; Chakhava, George...
Clinical Therapeutics.  42 (2020)  12 - p. 2254-2265.e3 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of eptinezumab in patients with chronic..:

Lipton, Richard B. ; Goadsby, Peter J. ; Smith, Jeff...
Neurology.  94 (2020)  13 - p. , 2020
Link: https://doi.org/10.1212/..
 
?
9

Population pharmacokinetic and exposure‐response analysis o..:

Baker, Brian ; Schaeffler, Barbara ; Beliveau, Martin...
Pharmacology Research & Perspectives.  8 (2020)  2 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
10

Differences in Exposure Between Intravenously (IV) Administ..:

Baker, Brian ; Beliveau, Martin ; Pederson, Susan.
Neurology.  94 (2020)  15_supplement - p. , 2020
Link: https://doi.org/10.1212/..
 
?
11

Eptinezumab in episodic migraine: A randomized, double-blin..:

Ashina, Messoud ; Saper, Joel ; Cady, Roger...
Cephalalgia.  40 (2020)  3 - p. 241-254 , 2020
Link: https://doi.org/10.1177/..
 
?
12

Improving user satisfaction via a case‐enhanced e‐learning ..:

Jeong Kim, Hye ; Pederson, Susan ; Baldwin, Moira
Education + Training.  54 (2012)  2/3 - p. 204-218 , 2012
Link: https://doi.org/10.1108/..
 
?
13

B-lymphocyte stimulator/a proliferation-inducing ligand het..:

Dillon, Stacey R ; Harder, Brandon ; Lewis, Kenneth B...
Arthritis Research & Therapy.  12 (2010)  2 - p. R48 , 2010
Link: https://doi.org/10.1186/..
 
?
14

Preclinical safety of recombinant human thrombin:

Heffernan, Jane K. ; Ponce, Rafael A. ; Zuckerman, Linda A....
Regulatory Toxicology and Pharmacology.  47 (2007)  1 - p. 48-58 , 2007
Link: https://doi.org/10.1016/..
 
?
15

Preclinical Safety and Pharmacokinetics of Recombinant Huma..:

Ponce, Rafael A. ; Visich, Jennifer E. ; Heffernan, Jane K....
Toxicologic Pathology.  33 (2005)  4 - p. 495-506 , 2005
Link: https://doi.org/10.1080/..
 
1-15